Synthesis and antihypertensive activity of novel 3-benzyl-2-substituted-3H-[1,2,4]triazolo[5,1-b]quinazolin-9-ones

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 10, 2007, Pages 3457-3462

  Alagarsamy, Veerachamy ^a   Pathak, Urvishbhai S ^b  

^a Kumarswamy Layout   (India)

^b L M COLLEGE OF PHARMACY   (India)

Author keywords

Antihypertensive agents; Quinazoline; Triazoloquinazoline

Indexed keywords

3 AMINO 2 BENZYLAMINO 3H QUINAZOLIN 4 ONE; 3 BENZYL 2 (4 ETHOXYPHENYL) 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 2 (4 METHOXYPHENYL) 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 2 (4 METHYLPHENYL) 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 2 (MORPHLINYLMETHYL) 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 2 (PIPERIDYLMETHYL) 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 2 CHLOROMETHYL 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 2 METHYL 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 2 PHENYL 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 2 PROPYL 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; 3 BENZYL 3H [1,2,4]TRIAZOLO[5,1 B]QUINAZOLIN 9 ONE; ANTHRANILIC ACID METHYL ESTER; ANTIHYPERTENSIVE AGENT; CARBON; PRAZOSIN; QUINAZOLINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ESSENTIAL HYPERTENSION; NONHUMAN; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; QUINAZOLINONES; RATS; RATS, INBRED SHR; SPECTROPHOTOMETRY, INFRARED;

RATTUS;

EID: 34047188045     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.03.007     Document Type: Article

References (15)

1. De S.M.A. Drugs 54 (1997) 54
2. Garcia J.D., Somanathan R., Rivero I.A., Aguirre G., and Hellberg L.H. Synth. Commun. 30 (2000) 2707
3. Ram V.S., and Stasko J.J. J. Prakt. Chem. 32 (1990) 628
4. Alagarsamy V., Venkatesaperumal R., Vijayakumar S., Angayarkanni T., Pounammal P., Senthilganesh S., and Kandeeban S. Pharmazie 57 (2002) 306
5. Alagarsamy V. Pharmazie 59 (2004) 753
6. Alagarsamy V., Solomon V.R., Vanikavitha G., Paluchamy V., Ravichandran M., Arnaldsujin A., Thangathirupathy A., Amuthalakshmi S., and Revathi R. Biol. Pharm. Bull. 25 (2002) 1432
7. Alagarsamy V., Murugananthan G., and Venkateshperumal R. Biol. Pharm. Bull. 26 (2003) 1711
8. MannJen H., Li Jiau H., Sheng Chu K., Yi Bastow X., Kenneth B., Hamel N.Y., Lee E., and Hsiung K. J. Med. Chem. 43 (2000) 4479
9. Alagarsamy V., Revathi R., Meena S., Ramaseshu K.V., Rajasekaran S., and De Clercq E. Indian J. Pharm. Sci. 66 (2004) 459
10. Wammoff W., and George R. Chem. Ber. 118 (1985) 863
11. Chien L.K., and Ming H. Arch. Pharm. 31 (1986) 188
12. Zhohghna Y. Zaghi 45 (1993) 53
13. Alagarsamy V., and Pathak U.S. Indian Drugs 37 (2000) 51
14. Pathak U.S., and Alagarsamy V. Acta Pharm. Turc. 61 (1999) 37
15. Rodrigues B., Goyal R.K., and Mc Neill M. J. Pharmacol. Exp. Ther. 237 (1986) 292